- Allstate accuses Titan Diagnostic Imaging of submitting more than $1.3 mn in fraudulent no-fault insurance bills across more than 9,000 claims involving 59 clinic locations.
- The insurer alleges that medical necessity letters, diagnostic interpretations and test results were virtually identical across patients, with services performed through an improperly licensed operation.
- Allstate seeks to recover $179,689.87 already paid, obtain triple damages under RICO and eliminate liability for approximately $1.12 mn in outstanding bills.
Allstate has filed a federal racketeering lawsuit against Titan Diagnostic Imaging Services and its sole owner, alleging that the company submitted more than $1.3 mn in fraudulent medical bills for diagnostic procedures performed on New York no-fault auto insurance claimants.
The complaint, filed October 7 in the US District Court for the Eastern District of New York, accuses Titan of billing for tests described as “medically unnecessary, illusory, unlawfully rendered.”
According to Allstate, the alleged scheme involved more than 9,000 claims processed through 59 clinic locations, with medical documentation and diagnostic findings repeatedly showing identical language and results.
The lawsuit contains five causes of action, including two federal claims under the Racketeer Influenced and Corrupt Organizations Act (RICO), common law fraud, unjust enrichment and a request for declaratory relief concerning Titan’s pending and future billing.
Allstate says it paid Titan $179.7K before identifying the suspected irregularities. The insurer is seeking reimbursement of those payments and a judicial declaration that it has no obligation to pay approximately $1.12 bn in outstanding bills that Titan continues to pursue.
A central allegation concerns Titan’s legal authority to provide and bill for medical services in New York.
According to the complaint, Titan was not organized as a professional medical corporation and had never registered with the New York State Education Department, a requirement for entities providing professional medical services. Allstate also alleges that the company’s sole owner was not a licensed healthcare professional.
Despite these alleged deficiencies, Titan billed the insurer for musculoskeletal ultrasound examinations, videonystagmography and transcranial Doppler studies.
Videonystagmography evaluates vestibular function by measuring eye movements, while transcranial Doppler examinations use ultrasound to assess blood flow in the brain.
The complaint questions both the medical necessity of these procedures and the circumstances under which they were performed.
Allstate points to extensive similarities in the documentation used to justify the tests. According to the filing, Titan submitted “Letters of Medical Necessity” containing the same referral language regardless of the claimant’s injuries, symptoms or clinical circumstances.
Each letter stated that the patient “has been referred for musculoskeletal diagnostic sonogram to evaluate his/her acute/subacute/chronic pain and segmental dysfunction of the joints and muscles of the back.”
The insurer alleges that this uniformity extended to the diagnostic findings themselves. Interpretations of vestibular examinations reportedly contained identical summaries, clinical impressions and recommendations across virtually every patient, with almost all results reported as negative.
Transcranial Doppler examinations allegedly produced the same conclusions and normal findings in every case. Allstate argues that such consistency is medically implausible given the differences in patients’ accident histories, reported injuries and individual medical circumstances.
The complaint further describes an operation distributed across 59 clinics in New York, including locations in the Bronx, Brooklyn and Buffalo, rather than a single diagnostic facility.
In October, Allstate also has filed three federal lawsuits against New York pharmacies, alleging they used similar arrangements with no-fault medical clinics to bill hundreds of thousands of dollars for expensive prescription pain treatments.
The complaints were filed Sept. 30, 2026, in the U.S. District Court for the Eastern District of New York against Narrow Pharmacy Inc. in Brooklyn, Redfern Drugs Inc. in Far Rockaway and Punjab Rx Pharmacy Inc. in South Richmond Hill.
The plaintiffs are Allstate Insurance Company, Allstate Fire and Casualty Insurance Company, Allstate Indemnity Company and Allstate Property and Casualty Insurance Company.
Allstate characterizes the participating clinics as “medical mills established for the sole purpose of submitting inflated, fraudulent billing.”
In certain cases, as many as 23 separate entities allegedly billed Allstate for services provided to the same patient at the same clinic following a single motor vehicle accident.
The insurer also challenges the clinical justification for performing musculoskeletal ultrasounds on patients who had already undergone magnetic resonance imaging of the same anatomical regions.
Some ultrasound examinations allegedly occurred on the same day as the corresponding MRI scans. The complaint maintains that performing an ultrasound shortly after an MRI of the same area “virtually never provides any additional information.”
The timing of other examinations raised further concerns. Allstate identifies examples of ultrasounds performed on the day of an accident, three days afterward or during the first week following an injury.
According to the insurer, these procedures occurred before the 30-day period of conservative treatment that legitimate medical providers would typically allow before ordering additional diagnostic testing.
Allstate contends that the recurring documentation, consistently normal results, questionable testing practices and alleged licensing violations support its claims that Titan improperly sought reimbursement under New York’s no-fault insurance system.
